Organisation paid for research Program year 2025 Source: CMS Open Payments

Avacare

Neither a doctor nor a teaching hospital

Research payments

$75,275

5 payments

Through program year 2025, Avacare is reported as receiving $75,275 in research payments, across 5 payments.

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$75,275	5

Breakdown

Who paid Research payments · program year 2025

AstraZeneca UK Limited $40,275 2 payments
Lumos Diagnostics, Inc. $30,000 2 payments
AstraZeneca Pharmaceuticals LP $5,000 1 payment

Studies the money was for Research payments · program year 2025

AIRE Mobile Unit Mobile Prescreening Protocol $40,275 2 payments
CLP 0019 FebriDx Method Comparison Study Protocol $25,500 1 payment
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older $5,000 1 payment
CLP-0021 FebriDx Pediatric Validation Study Protocol $4,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.